Details for New Drug Application (NDA): 022204
✉ Email this page to a colleague
The generic ingredient in GELNIQUE is oxybutynin. There are sixteen drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the oxybutynin profile page.
Summary for 022204
Tradename: | GELNIQUE |
Applicant: | Abbvie |
Ingredient: | oxybutynin chloride |
Patents: | 3 |
Pharmacology for NDA: 022204
Mechanism of Action | Cholinergic Muscarinic Antagonists |
Suppliers and Packaging for NDA: 022204
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
GELNIQUE | oxybutynin chloride | GEL;TRANSDERMAL | 022204 | NDA | Allergan, Inc. | 0023-5861 | 0023-5861-11 | 30 PACKET in 1 CARTON (0023-5861-11) / 1 g in 1 PACKET (0023-5861-10) |
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | GEL;TRANSDERMAL | Strength | 10% (100MG/PACKET) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | ||||
Approval Date: | Jan 27, 2009 | TE: | RLD: | Yes | |||||
Patent: | ⤷ Sign Up | Patent Expiration: | Nov 6, 2029 | Product Flag? | Y | Substance Flag? | Delist Request? | ||
Patented Use: | TREATMENT OF PATIENTS WITH AN OVERACTIVE BLADDER WITH SYMPTOMS OF URINARY FREQUENCY, URGENCY, OR URGE INCONTINENCE WITH A SINGLE UNIT DOSE OF 10% OXYBUTYNIN CHLORIDE GEL | ||||||||
Patent: | ⤷ Sign Up | Patent Expiration: | Mar 26, 2031 | Product Flag? | Substance Flag? | Delist Request? | |||
Patented Use: | TREATMENT OF OVERACTIVE BLADDER BY APPLICATION OF OXYBUTYNIN CHLORIDE GEL TO SKIN | ||||||||
Patent: | ⤷ Sign Up | Patent Expiration: | Nov 6, 2029 | Product Flag? | Substance Flag? | Delist Request? | |||
Patented Use: | TREATMENT OF OVERACTIVE BLADDER BY APPLICATION OF OXYBUTYNIN CHLORIDE GEL TO SKIN |
Expired US Patents for NDA 022204
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Abbvie | GELNIQUE | oxybutynin chloride | GEL;TRANSDERMAL | 022204-001 | Jan 27, 2009 | ⤷ Sign Up | ⤷ Sign Up |
Abbvie | GELNIQUE | oxybutynin chloride | GEL;TRANSDERMAL | 022204-001 | Jan 27, 2009 | ⤷ Sign Up | ⤷ Sign Up |
Abbvie | GELNIQUE | oxybutynin chloride | GEL;TRANSDERMAL | 022204-001 | Jan 27, 2009 | ⤷ Sign Up | ⤷ Sign Up |
Abbvie | GELNIQUE | oxybutynin chloride | GEL;TRANSDERMAL | 022204-001 | Jan 27, 2009 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Complete Access Available with Subscription